Table 1 Patient characteristics

From: Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer

Variable

No. of patients (%)

Enrolled patients

41

Age (years)

 Median (range)

59 (37–72)

Sex

 Male

22 (53.7)

 Female

19 (46.3)

Performance status

 ECOG, 0–1

23 (56.1)

 ECOG, 2

18 (43.9)

Diabetes mellitus

13 (31.7)

Symptoms at baseline

 Abdominal pain

31 (75.6)

 Jaundice

15 (36.6)

 Weight loss

22 (53.7)

Tumour site

 Head

26 (63.4)

 Body

12 (29.3)

 Tail

3 (7.3)

Tumour size (longest diameter, cm)

 Median (range)

3.2 (1.5–9.0)

Tumour stage

 

 IIA

8 (19.5)

 IIB

3 (7.3)

 III

30 (73.2)

CA 19-9 (U ml−1) increased

33 (80.5)

 Median (range)

686 (51–20 000)

  1. ECOG=Easter Cooperative Oncology Group.